Abstract
Blood transfusion is a vital therapy in treating and preventing the complications of myelodysplastic syndromes (MDS). Although transfusions of packed red blood cells significantly improve quality of life in this patient population, their use is limited due to the high incidence of alloimunization, a serious complication in patients with MDS that can result in Delayed Hemolytic Transfusion…